To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac ( and Bavarian Nordic (OMX: BAVA, OTC: BVNRY).

Read more:



VAR2 Pharmaceuticals ApS

Ole Maal√łes Vej 3
DK-2200 Copenhagen N
CVR: 34621942

T: +45 78 70 19 00